Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial.

He HuangYu LiuWei ShuaiChen-Yang JiangMenghe ZhangXiufen QuWenqing ZhengHao YangFan LiuBo YuManhua ChenBin MuChen YaoYanhong TangCongxin HuangFeifan OuyangZhenhua Jia

Published in: European heart journal (2024)

Treatment with SSYX following radiofrequency catheter ablation for persistent AF reduced the incidence of recurrent atrial tachyarrhythmias and led to clinically significant improvements in QoL during a 12-month follow-up in a Chinese population.

Keyphrases

catheter ablation
atrial fibrillation
left atrial
left atrial appendage
oral anticoagulants
direct oral anticoagulants
heart failure
clinical trial
risk factors
percutaneous coronary intervention
study protocol
phase ii
randomized controlled trial
coronary artery disease
combination therapy